ABSTRACT: The first syntheses of tubastrine and 3-dehydroxy tubastrine are described. The target compounds were prepared in four consecutive steps from commercially available starting materials. The central scaffold was formed by a microwave-assisted C-N crosscoupling reaction between 1,3-bis(tert-butoxycarbonyl)-guanidine and (E)-((4-(2-iodovinyl)-2 1,2-phenylene)bis(oxy))bis(tert-butyldimethylsilane) and (E)-tert-butyl(4-(2-iodovinyl)phenoxy)-dimethylsilane, respectively. The aryl vinyl iodides were obtained by a
Introduction
Tubastrine (1), and 3-dehydroxy tubastrine (2) , shown in Figure 1 , are two guanidine containing natural products. The former was first isolated from the coral Tubastrea aurea by Sakai et al. in 1987. 1 In recent years tubastrine has also been found in a Dendrodoa specie, Dendrodoa grossularia, and the ascidian Ascidiella scabra, both collected from the Orkney Islands, 2 as well as in a New Zealand ascidian, Aplidium orthium. 3 Tubastrine showed antiviral, 1 anticancer, antimicrobial 2 and anti-inflammatory activity, 3 making it an interesting starting point for further SAR studies. 3-Dehydroxy tubastrine, in turn, has been isolated from an Australian marine sponge, Spongosorites sp., 4 as well as in the sub-arctic ascidian, 5 and displayed antimicrobial activity against several bacteria such as 4 and Corynebacterium glutamicum. To the best of our knowledge, tubastrines 1 and 2 have not yet been synthesized. One attempt to prepare compound 2 has been reported in the literature, however, the synthesis failed in the final step. 6 Our endeavor into the tubastrines, motivated by their biological activity, required a convergent approach that could easily generate analogous compounds.
Dendrodoa aggregate

Staphylococcus aureus, Serratia sp., Escherichia coli
Two obvious disconnections could be envisioned (Scheme 1). Disconnection A corresponds to a Heck cross-coupling reaction 7 between the respective aryl halides and protected vinylguanidines, while disconnection B corresponds to a C-N cross-coupling reaction 8 between the respective aryl vinyl halides and protected guanidines. In the following, we present the first synthesis of tubastrine (1) and 3-dehydroxy tubastrine (2) following the above outlined strategy.
Scheme 1. Retrosynthetic analysis of tubastrine (1) and 3-dehydroxy tubastrine (2).
Results and discussion
5 vinyl bromide 6 and -iodide 7a in 83% and 80% yields, respectively. Acid 5a was either obtained by hydrolysis of ester 4 with NaOH in methanol/water in 77% isolated yield (Scheme 2) or from commercial sources.
Next, a C-N cross-coupling reaction 11 between 1,3-bis(tert-butoxycarbonyl)guanidine (8) and either aryl vinyl bromide 6 or aryl vinyl iodide 7a forming the protected tubastrine precursor 9a was investigated. Using different conditions (ligands, catalyst, heating source, solvents, base and reaction time), product 9a was formed in yields as shown in Table 1 and Table 2 . Microwave-assisted reactions gave improved yields of 9a (49%; Entry 6, Table 1) compared to traditional heating using an oil bath at 65 °C (22%; Entry 1, Table 1 ). The aryl vinyl iodide 7a performed better in the cross-coupling reaction (Entries 6 and 7, -(2-hydroxybenzoyl) pyrrolidine (L5) and 1,10-phenanthroline (L7) gave no trace of product (Entries 8-11, Table 1 ). No product was observed when CuI was used as catalyst without ligands (Entry 14, Table 1 ). The ideal reaction time was found to be 35 min (Entries 2, 5-7
and 12, Table 1 ), since longer reaction time decreased the yield of product 9a (Entry 3, Table   1 ). Table 2 ) than one equivalent (Entry 2, Table 2 ), while four equivalents gave a significant decrease in the yield of product 9a (Entry 4, Table 2 ). The Boc groups in compound 9a and 9b were easily removed using TFA at 100 °C (microwave) for 20 min. The removal of the methoxy groups in substrate 9a and 9b was more difficult than first anticipated. Treatment with BBr 3 gave an intractable mixture of products, while a premixture of NaI and TMSCl 12 was inefficient in the removal of the methoxy groups.
Due to the difficulties with the final deprotection of substrate 9a and 9b, the corresponding tert-butyldimethylsilyl (TBDMS) protected analogues were envisioned to be better precursors for target compounds 1 and 2.
The TBDMS protected analogues 9c and 9d were prepared by the established strategy (Scheme 4). Commercially available trans-caffeic acid (10) and p-coumaric acid (11) were silylated with TBDMSCl / Et 3 N in CH 2 Cl 2, followed by hydrolysis of the silyl ester with K 2 CO 3 in methanol/water to afford the protected aryl acrylic acids 5c and 5d in 76% and 44%
yields. 10b,13 The Hunsdiecker-Borodin-type reaction 10 of 5c and 5d with NIS gave aryl vinyl iodides 7c and 7d in 71% and 74% yield, respectively. In the microwave-assisted C-N crosscoupling reaction with guanidine 8 products 9c and 9d were formed in 45% or 37% yield, respectively. The synthesis was completed by desilylation with tetrabutylammonium fluoride 10 (TBAF), followed by a Boc deprotection using TFA, providing target compounds 1 and 2 in 64% and 61% yield, respectively. (1) / 61% (2).
Scheme 4. Reagent and conditions: (a) (i) Et
Conclusion
The first total synthesis of tubastrine (1) and 3-dehydroxy tubastrine (2) were completed utilizing a microwave-assisted C-N cross-coupling reaction between 1,3-bis(tertbutoxycarbonyl)guanidine (8) and (
respectively (7d). Target compounds 1 and 2 were prepared in four steps from commercial available starting materials with overall yields of 15.5% and 7.3%, respectively. The total synthesis opens up for further biological evaluation of the two natural products and analogues thereof.
Experimental
General
Acetonitrile (MeCN) was dried over molecular sieves (oven dried) three times, and stored over molecular sieves under nitrogen atmosphere. Anhydrous Toluene, THF and CH 2 Cl 2 were purchased from VWR and used as received. N,N'-Dimethylethylenediamine (DMEDA) was distilled and stored over KOH, the same was Et 3 N. Copper(I)iodide was recrystallized from potassium iodide solution (concentrated) and water, and dried in an oven prior to use. All reactions were carried out under argon atmosphere if not otherwise specified. The microwave reactions were performed in 10 mL pressure vials with caps using Discover SP from CEM.
TLC was performed on Merck silica gel 60 F 254 plates, using UV light at 254 nm and 5% 
(E)-Methyl 3-(3,4-dimethoxyphenyl)acrylate (4)
4-Bromoveratrol (3) 
(E)-3-(3,4-Dimethoxyphenyl)acrylic acid (5a)
To a solution of acrylate 4 (1.997 g, 8.98 mmol) in MeOH (50 mL) and water (5 mL 
(E)-3-(4-((tert-Butyldimethylsilyl)oxy)phenyl)acrylic acid (5d)
(E)-4-(2-Iodovinyl)-1,2-dimethoxybenzene (7a)
To a solution of acrylic acid 5a (1.088 g, 5.23 mmol) 
(E)-1-(2-Iodovinyl)-4-methoxybenzene (7b)
To a solution of 4-methoxycinnamic acid (1.028 g, 5.77 mmol) in MeCN : H 2 O (19:1, 60 mL) was added LiOAc (77 mg, 1.17 mmol) and NIS (1.291 g, 5.74 mmol) at room temperature.
The orange mixture was stirred at room temperature for 1 h before concentrated in vacuo on silica gel. The crude product was purified by flash column chromatography (petroleum ether: 
(E)-((4-(2-Iodovinyl)-1,2-phenylene)bis(oxy))bis(tert-butyldimethylsilane) (7c)
To a 
(E)-tert-Butyl(4-(2-iodovinyl)phenoxy)dimethylsilane (7d)
(Z)-1-((E)-3,4-Dimethoxystyryl)-2,3-bis(tert-butoxycarbonyl)guanidine (9a)
A 
(Z)-1-((E)-4-Methoxystyryl)-2,3-bis(tert-butoxycarbonyl)guanidine (9b)
A Butyldimethylsilyl) and TFA (0.02 mL, 0.27 mmol) in MeCN (2 mL) was microwave heated (100 W, 100 °C) for 20 min, cooled to room temperature and concentrated in vacuo. The crude product was purified by a C18-column using water : MeCN gradient to obtain 14 mg (67% (64% from 9c) 
(Z)-1-((E)-4-((tert-
3-Dehydroxy-tubastrine (2)
To a solution of compound 9d (47 mg, 0.096 mmol) in THF (3 mL) was added TBAF (1 M in THF, 0.12 mL, 0.12 mmol) dropwise at room temperature. 
